VA Resident Report: What are the adverse effects of PPI use on B12 levels?

The Bottom Line: Studies of PPI use and vitamin B12 deficiency have yielded mixed results. Absorption decreased from 3.2 to 0.9% (P ¼ 0.031) in patients on omeprazole 20 mg daily, and from 3.4 to 0.4% in patients on higher doses. Chronic PPI therapy was associated with a 46% decline in median serum B12 levels and subnormal levels in 10% of patients. Others have reported no decreased absorption of vitamin B12 . Older patients are at greatest risk and more likely to have borderline baseline levels.

References: Abraham, N. (2012). Proton pump inhibitors: Potential adverse effects. Current Opinion in Gastroenterology, 28(6), 615-620.   

Summary: High-dose, chronic PPI use is prevalent, despite a high degree of comorbidity in the target population and significant treatment failures . Clinicians must remain cognizant of potential threats and ensure vigilance in their prescribing habits. PPI prescription must be tailored, using an individualized approach that limits use to robust indications

This entry was posted in VA and tagged . Bookmark the permalink.